Download PDF
Am J Perinatol 2017; 34(05): 486-492
DOI: 10.1055/s-0036-1593536
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Severe Vitamin D Deficiency in Human Immunodeficiency Virus-Infected Pregnant Women is Associated with Preterm Birth

Jennifer Jao
1   Department of Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York
2   Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York
,
Laura Freimanis
3   Westat, Inc., Rockville, Maryland
,
Marisa M. Mussi-Pinhata
4   Universidade de São Paulo, Brazil, Faculdade de Medicina de Ribeirão Preto, São Paulo, São Paulo, Brazil
,
Rachel A. Cohen
3   Westat, Inc., Rockville, Maryland
,
Jacqueline Pontes Monteiro
4   Universidade de São Paulo, Brazil, Faculdade de Medicina de Ribeirão Preto, São Paulo, São Paulo, Brazil
,
Maria Leticia Cruz
5   Hospital Federal dos Servidores do Estado, Brazil, Serviço de Doenças Infecciosas e Parasitárias, Rio de Janeiro, Brazil
,
Andrea Branch
2   Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York
,
Rhoda S. Sperling
1   Department of Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York
,
George K. Siberry
6   Eunice Kennedy Shriver National Institute of Child Health and Human Development, Maternal and Pediatric Infectious Disease Branch, Bethesda, Maryland
,
for the NISDI LILAC Protocol › Author Affiliations
Further Information

Publication History

18 July 2016

31 August 2016

Publication Date:
07 October 2016 (online)

    Permissions and Reprints

Abstract

Background Low maternal vitamin D has been associated with preterm birth (PTB). Human immunodeficiency virus (HIV)-infected pregnant women are at risk for PTB, but data on maternal vitamin D and PTB in this population are scarce.

Methods In a cohort of Latin American HIV-infected pregnant women from the National Institute of Child Health and Human Development International Site Development Initiative protocol, we examined the association between maternal vitamin D status and PTB. Vitamin D status was defined as the following 25-hydroxyvitamin D levels: severe deficiency (< 10 ng/mL), deficiency (10–20 ng/mL), insufficiency (21–29 ng/mL), and sufficiency (≥30 ng/mL). PTB was defined as delivery at < 37 weeks' gestational age (GA). Logistic regression was used to assess the association between maternal vitamin D status and PTB.

Results Of 715 HIV-infected pregnant women, 13 (1.8%) were severely vitamin D deficient, 224 (31.3%) were deficient, and 233 were (32.6%) insufficient. Overall, 23.2% (166/715) of pregnancies resulted in PTB (median GA of PTBs = 36 weeks [interquartile range: 34–36]). In multivariate analysis, severe vitamin D deficiency was associated with PTB (odds ratio = 4.7, 95% confidence interval: 1.3–16.8]).

Conclusion Severe maternal vitamin D deficiency is associated with PTB in HIV-infected Latin American pregnant women. Further studies are warranted to determine if vitamin D supplementation in HIV-infected women may impact PTB.

Keywords

vitamin D - preterm birth - HIV - pregnant women - pregnancy

Note

The authors have no financial disclosures to make. The findings and conclusions in this article are those of the authors and do not necessarily represent the views of the National Institutes of Health or the Department of Health and Human Services.


* The members of the NISDI Perinatal Study Group may be found in Appendix.


 

  • References

  • 1 Triunfo S, Lanzone A. Potential impact of maternal vitamin D status on obstetric well-being. J Endocrinol Invest 2016; 39 (1) 37-44
    CrossrefPubMedGoogle Scholar
  • 2 Nour NM. Premature delivery and the millennium development goal. Rev Obstet Gynecol 2012; 5 (2) 100-105
    PubMedGoogle Scholar
  • 3 Bodnar LM, Platt RW, Simhan HN. Early-pregnancy vitamin D deficiency and risk of preterm birth subtypes. Obstet Gynecol 2015; 125 (2) 439-447
    CrossrefPubMedGoogle Scholar
  • 4 Dawodu A, Nath R. High prevalence of moderately severe vitamin D deficiency in preterm infants. Pediatr Int 2011; 53 (2) 207-210
    CrossrefPubMedGoogle Scholar
  • 5 Morley R, Carlin JB, Pasco JA, Wark JD. Maternal 25-hydroxyvitamin D and parathyroid hormone concentrations and offspring birth size. J Clin Endocrinol Metab 2006; 91 (3) 906-912
    Google Scholar
  • 6 Perez-Ferre N, Torrejon MJ, Fuentes M , et al. Association of low serum 25-hydroxyvitamin D levels in pregnancy with glucose homeostasis and obstetric and newborn outcomes. Endocr Pract 2012; 18 (5) 676-684
    CrossrefPubMedGoogle Scholar
  • 7 Wagner CL, Baggerly C, McDonnell S , et al. Post-hoc analysis of vitamin D status and reduced risk of preterm birth in two vitamin D pregnancy cohorts compared with South Carolina March of Dimes 2009-2011 rates. J Steroid Biochem Mol Biol 2016; 155 (Pt B): 245-251
    CrossrefPubMedGoogle Scholar
  • 8 Wagner CL, Baggerly C, McDonnell SL , et al. Post-hoc comparison of vitamin D status at three timepoints during pregnancy demonstrates lower risk of preterm birth with higher vitamin D closer to delivery. J Steroid Biochem Mol Biol 2015; 148: 256-260
    CrossrefPubMedGoogle Scholar
  • 9 Wei SQ, Qi HP, Luo ZC, Fraser WD. Maternal vitamin D status and adverse pregnancy outcomes: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2013; 26 (9) 889-899
    CrossrefPubMedGoogle Scholar
  • 10 Zhu T, Liu TJ, Ge X, Kong J, Zhang LJ, Zhao Q. High prevalence of maternal vitamin D deficiency in preterm births in northeast China, Shenyang. Int J Clin Exp Pathol 2015; 8 (2) 1459-1465
    PubMedGoogle Scholar
  • 11 Chen JY, Ribaudo HJ, Souda S , et al. Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana. J Infect Dis 2012; 206 (11) 1695-1705
    CrossrefPubMedGoogle Scholar
  • 12 Townsend C, Schulte J, Thorne C , et al; Pediatric Spectrum of HIV Disease Consortium, the European Collaborative Study and the National Study of HIV in Pregnancy and Childhood. Antiretroviral therapy and preterm delivery-a pooled analysis of data from the United States and Europe. BJOG 2010; 117 (11) 1399-1410
    CrossrefPubMedGoogle Scholar
  • 13 Mehta S, Hunter DJ, Mugusi FM , et al. Perinatal outcomes, including mother-to-child transmission of HIV, and child mortality and their association with maternal vitamin D status in Tanzania. J Infect Dis 2009; 200 (7) 1022-1030
    Google Scholar
  • 14 Read JS, Duarte G, Hance LF , et al; NISDI Perinatal Study Group. The NICHD International Site Development Initiative perinatal cohorts (2002-09). Int J Epidemiol 2012; 41 (3) 642-649
    CrossrefPubMedGoogle Scholar
  • 15 Ballard JL, Khoury JC, Wedig K, Wang L, Eilers-Walsman BL, Lipp R. New Ballard Score, expanded to include extremely premature infants. J Pediatr 1991; 119 (3) 417-423
    CrossrefPubMedGoogle Scholar
  • 16 Dubowitz LM, Dubowitz V, Goldberg C. Clinical assessment of gestational age in the newborn infant. J Pediatr 1970; 77 (1) 1-10
    CrossrefPubMedGoogle Scholar
  • 17 Attico NB, Meyer DJ, Bodin HJ, Dickman DS. Gestational age assessment. Am Fam Physician 1990; 41 (2) 553-560
    PubMedGoogle Scholar
  • 18 Szyld EG, Warley EM, Freimanis L , et al; NISDI Perinatal Study Group. Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth. AIDS 2006; 20 (18) 2345-2353
    CrossrefPubMedGoogle Scholar
  • 19 Abbott Architect System 25OHD [package insert]. Abbott Park, IL: Abbott Laboratories; 2011
    Google Scholar
  • 20 Jao J, Freimanis L, Mussi-Pinhata MM , et al; NISDI LILAC Protocol. Low vitamin D status among pregnant Latin American and Caribbean women with HIV Infection. Int J Gynaecol Obstet 2015; 130 (1) 54-58
    CrossrefPubMedGoogle Scholar
  • 21 Holick MF, Binkley NC, Bischoff-Ferrari HA , et al; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96 (7) 1911-1930
    CrossrefPubMedGoogle Scholar
  • 22 Argentina Ministry of Health. National Data from Maternity and Childhood, health care program for women, children and teenagers. Available from: http://www.msal.gov.ar/promin/archivos/softs/nutri13.zip . Accessed April 11, 2013
    PubMedGoogle Scholar
  • 23 Villar J, Cheikh Ismail L, Victora CG , et al; International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st). International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project. Lancet 2014; 384 (9946): 857-868
    CrossrefPubMedGoogle Scholar
  • 24 Baker AM, Haeri S, Camargo Jr CA, Stuebe AM, Boggess KA. A nested case-control study of first-trimester maternal vitamin D status and risk for spontaneous preterm birth. Am J Perinatol 2011; 28 (9) 667-672
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Shand AW, Nassar N, Von Dadelszen P, Innis SM, Green TJ. Maternal vitamin D status in pregnancy and adverse pregnancy outcomes in a group at high risk for pre-eclampsia. BJOG 2010; 117 (13) 1593-1598
    CrossrefPubMedGoogle Scholar
  • 26 Christiaens I, Zaragoza DB, Guilbert L, Robertson SA, Mitchell BF, Olson DM. Inflammatory processes in preterm and term parturition. J Reprod Immunol 2008; 79 (1) 50-57
    CrossrefPubMedGoogle Scholar
  • 27 Díaz L, Noyola-Martínez N, Barrera D , et al. Calcitriol inhibits TNF-alpha-induced inflammatory cytokines in human trophoblasts. J Reprod Immunol 2009; 81 (1) 17-24
    CrossrefPubMedGoogle Scholar
  • 28 Tamblyn JA, Hewison M, Wagner CL, Bulmer JN, Kilby MD. Immunological role of vitamin D at the maternal-fetal interface. J Endocrinol 2015; 224 (3) R107-R121
    CrossrefPubMedGoogle Scholar
  • 29 Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2008; 8 (9) 685-698
    CrossrefPubMedGoogle Scholar
  • 30 Harrison MS, Goldenberg RL. Global burden of prematurity. Semin Fetal Neonatal Med 2016; 21 (2) 74-79
    CrossrefPubMedGoogle Scholar
  • 31 Powis KM, Smeaton L, Hughes MD , et al. In-utero triple antiretroviral exposure associated with decreased growth among HIV-exposed uninfected infants in Botswana. AIDS 2016; 30 (2) 211-220
    CrossrefPubMedGoogle Scholar
  • 32 Jao J, Agwu A, Mhango G , et al. Growth patterns in the first year of life differ in infants born to perinatally vs. nonperinatally HIV-infected women. AIDS 2015; 29 (1) 111-116
    CrossrefPubMedGoogle Scholar
  • 33 Baroncelli S, Galluzzo CM, Mancinelli S , et al. Antibodies against pneumococcal capsular polysaccharide in Malawian HIV-positive mothers and their HIV-exposed uninfected children. Infect Dis (Lond) 2015; 1-5
    PubMedGoogle Scholar
  • 34 Manzon L, Altarescu G, Tevet A , et al. Vitamin D receptor polymorphism FokI is associated with spontaneous idiopathic preterm birth in an Israeli population. Eur J Obstet Gynecol Reprod Biol 2014; 177: 84-88
    CrossrefPubMedGoogle Scholar
  • 35 Catov JM, Bodnar LM, Olsen J, Olsen S, Nohr EA. Periconceptional multivitamin use and risk of preterm or small-for-gestational-age births in the Danish National Birth Cohort. Am J Clin Nutr 2011; 94 (3) 906-912
    CrossrefPubMedGoogle Scholar